NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
59 hedge funds and large institutions have $155M invested in NKGen Biotech, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
59
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.23M | |
| 2 | +$5.47M | |
| 3 | +$4.98M | |
| 4 |
CAC
Cowen and Company
New York
|
+$3.62M |
| 5 |
JPMorgan Chase & Co
New York
|
+$3.33M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$7.33M | |
| 3 | -$4.05M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$3.12M |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
-$2.08M |